Rubella susceptibility and continuing risk of infection in pregnancy by Rasul, Saadiya et al.
eCommons@AKU
Section of Haematology/Oncology Department of Medicine
January 1990
Rubella susceptibility and continuing risk of
infection in pregnancy
Saadiya Rasul
Aga Khan University
Mohammad Khurshid
Aga Khan University, mohammad.khurshid@aku.edu
Javaid Rizvi
Aga Khan University
Shahbanu Rizvi
Aga Khan University
Follow this and additional works at: http://ecommons.aku.edu/
pakistan_fhs_mc_med_haematol_oncol
Part of the Oncology Commons
Recommended Citation
Rasul, S., Khurshid, M., Rizvi, J., Rizvi, S. (1990). Rubella susceptibility and continuing risk of infection in pregnancy. Journal of
Pakistan Medical Association, 40, 102.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_med_haematol_oncol/23
RUBELLA SUSCEPTIBILITY AND CONTINUING RISK OF
INFECTION IN PREGNANCY
Pages with reference to book, From 102 To 103 
Saadiya Rasul, Mohammad Khurshid, Javaid Rizvi  ( Departments of Obstetrics and Gynaecology, The Aga Khan
University Hospital, Karachi-5. ) 
Shahbanu Rizvi  ( Departments of Pathology, The Aga Khan University Hospital, Karachi-5. ) 
ABSTRACT 
Sera of 2000 pregnant women attending the antenatal clinic of the Aga Khan University Hospital were
tested for rubella antibodies. Of these 1684(84.2%) were Immune and 316(15.8%) were susceptible to
rubella. Majority (99.8%) of the women were Asian in origin. Susceptibility decreased with increasing
age and parity. We conclude that apart from vaccination of all young children greater attention should
be paid to immunization of women of child-bearing age (JPMA 40 :102,1990).
INTRODUCTION 
Rubella (German measles) has been directly responsible for much pregnancy wastage and severe
congenital malformation in the live born infant including congenital deafness, mental retardation,
cerebral palsy, eye defects. Congenital rubella syndrome is preventable. In Great Britain the protective
strategy employed is to allow wild rubella virus to circulate among children so that approximately 50%
of women can enter their child-bearing years with naturally acquired immunity. Immunization of all
school girls aged 10-14 years is then employed with the aim of giving vaccine induced immunity to the
remaining 50% (Department of Health & Social Security 1970). In addition, vaccination is offered to
all women of child-bearing age who have been shown to lack antibodies against rubella,1 Overall the
incidence of congenital rubella has been declining over the past few years due to active immunization
programmes in the Western countries. The incidence of Congenital Rubefla Syndrome (CRS) in U.S.A.
in 1981—1983 was 0.9 - 1/1000. 2 Its incidence in Australia has declined from 2.05/100000 live births
to 0.043/100000 between 1963 — 1983 following an active rubella screening and immunization
programme. 3 There is little epidemiological data available in Pakistan regarding susceptibility to
rubella in pregnancy and the incidence of congenital rubella syndrome in the new born. Of the two
studies carried out in Pakistan the immunity to rubella in 262 married women, was 72%4 in one while
in another it was 77% in pregnant and 51.7% in pre-pubertal females5.
PATIENTS AND METHODS 
Routine antenatal screening for rubella on all women attending the antenatal clinic at the Aga Khan
University Hospital (AKUH), Karachi was carried out. A total of 2000 patients were screened from
January1987 to October 1988. Three ml of blood was drawn from patients at their first visit to the
antenatal clinic and rubella IgG and 1gM antibodies screening tests were done by the ELISA Technique
(Rubazyme, Abbott Laboratories).
RESULTS 
The results of the study are shown in tables 1 and II.
Of 2000 antenatal population screened, 15.8% were found susceptible to rubella, and the susceptibility
decreased with increasing age and parity. Majority (99.8%) of the females were of Asian origin.
Patients who were susceptible to rubella were offered immunization using live attenuated rubella
vaccine, (RA 27/3M strain USTAR — Rudivax). This is a safe non communicable and effective
method of prevention6-8.
DISCUSSION 
Congenital rubella syndrome is an important cause of preventable congenital defects in the newborn.
Worldwide efforts have been made to reduce the risk of foetal anomalies by immunizing the susceptible
female population of child bearing age. In the western world today the incidence of women susceptible
to rubella vary between 2.7 — 7.3%9,10. Ours is a descriptive study of rubella immunity status in
women visiting the antenatal clinics at a private hospital. These women are mostly urban, better
educated and relatively affluent. Therefore this data cannot be extrapolated to draw conclusions about
the immunity status in the whole female population of Pakistan. Further studies are required, but this
can serve as a model to conduct similar studies in defined geographical areas. We found that 84.2%
women of child bearing age were immune to Rubella. However, the percentage of susceptible women
is a cause of concern. Two previous studies4,5 have shown a susceptibility rate of 28% in married
women and 23% in pregnant women. Our figures are lower (15.8%) than these studies, but if age and
parity specific data are taken into account, the highest susceptibility rate was in women between 15 and
20 years of age (28.0%) and among primigravidas (23.3%). The incidence of susceptibility declines
with increasing age and parity. Parity has been shown to be an important factor in assessment of rubella
status and may reflect postpartum immunization. 11 Another factor is the exposure of parous women to
young children in their own and in neighbouring households. Such children may transmit wild rubella
virus. This source has previously been shown to explain the association between poliovirus infection
and parity12 and is a factor which must be controlled in further studies of rubella. The implications and
consequences of the congemtal rubella syndrome for the foetus are well known13 and can present
substantial physical, emotional and financial hardships for the children and the family. In order to
reduce the number of patients at risk, considerable efforts would be required and, until high vaccination
rates become the rule throughout the country, the seropositivity rates of women seeking antenatal care
may not improve. Such improvements cannot be achieved locally but will require intervention and
support at national/governmental level. Two main approaches have been used10 and can be adopted.
The first one is vaccination of all young children in order to prevent the spread of rubella to adult
pregnant women. The other is to vaccinate all teenage girls, thus giving individual protection against
rubella during their fertile period. In Pakistan there is a major drive for immunization in children. These
programmes are supported by grants from the government and the WH.O., but rubella immunization is
not included in their regular regimen.
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